Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate

CHEBI:CHEBI_754801

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2001424
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
route
ORAL
marketing_category
ANDA
dosage_form
TABLET, FILM COATED
pharm_class_moa
Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
pharm_class
Non-Nucleoside Analog [EXT]
active_ingredient_strength
600 mg/1
nui
N0000175656
active_ingredient_name
EFAVIRENZ
unii
2T8Q726O95
pharm_class_epc
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
labeler_name
Laurus Labs Limited
manufacturer_name
Laurus Labs Limited
marketing_start_date
20200514
package_marketing_start_date
20200514
generic_name
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
brand_name
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
brand_name_base
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
product_ndc
42385-928
application_number
ANDA212786
spl_id
27623aed-629d-4406-a0bf-4f234fc4e6c6
package_ndc
42385-928-90
package_description
90 TABLET, FILM COATED in 1 BOTTLE (42385-928-90)
spl_set_id
1f8f9fe1-b8fd-4f65-8832-9d3d6802d076
upc
0342385929317
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class